Health Catalyst, Inc.

  • Market Cap: Micro Cap
  • Industry: Software Products
  • ISIN: US42225T1079
USD
2.69
-0.07 (-2.54%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Health Catalyst, Inc. stock-summary
stock-summary
Health Catalyst, Inc.
Software Products
Health Catalyst Inc. is a provider of data and analytics technology and services to healthcare organizations. Its solution comprises a cloud-based data platform, analytics software, and professional services expertise. Its cloud-based data operating system (DOS) is a healthcare-specific, open, flexible, and scalable data platform that provides customers a single comprehensive environment to integrate and organize data from their disparate software systems, enabling a broad range of analytics. Its software analytics application is build on top of its data platform to provide foundational or domain-specific insights that improve customers’ clinical, financial, and operational performance. It serves the majority of customers through a subscription-based contract model. Its offered services include opportunity analysis and prioritization, data modeling and analysis, quality and process improvement strategy, and population health strategies. It offers its services to healthcare providers.
Company Coordinates stock-summary
Company Details
3165 E Millrock Dr Ste 400 , SALT LAKE CITY UT : 84121-4772
stock-summary
Tel: 1 801 70868001 855 3096800
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 58 Schemes (33.66%)

Foreign Institutions

Held by 90 Foreign Institutions (10.06%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Fraser Bullock
Independent Chairman of the Board
Mr. Daniel Burton
Chief Executive Officer, Director
Dr. Timothy Ferris
Director
Mr. Todd Cozzens
Independent Director
Mr. Duncan Gallagher
Independent Director
Mr. John Kane
Independent Director
Ms. Julie Larson-Green
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
81 Million
(Quarterly Results - Jun 2025)
Net Profit:
-41 Million
stock-summary
Industry

Software Products

stock-summary
Market cap

USD 238 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.17

stock-summary
Return on Equity

-17.92%

stock-summary
Price to Book

0.68